Exhalix, founded in Albuquerque, New Mexico, is dedicated to advancing medical diagnostics and therapeutics with a core mission to improve vascular health. The company specializes in non-invasive diagnostics and minimally invasive therapeutic technologies, particularly focusing on the detection and treatment of lower extremity vascular conditions. Their products include miniature sensors integrated into medical devices that measure blood flow and gases through cutaneous excretion, leveraging expertise in trace-level gas sensors, microfluidic systems, and microelectronic devices.
Notable individuals affiliated with Exhalix include experts in medical technology and microelectronics, although specific names are not publicly highlighted. The company has achieved significant milestones in developing innovative diagnostic tools that offer less invasive options for patients. Exhalix's impact is marked by its contribution to enhancing patient care through advanced sensor technology, potentially reducing the need for more invasive procedures and improving early detection and treatment of vascular health issues.